Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare decision pending on Parkinson's therapy:

This article was originally published in Clinica

Executive Summary

The Medical and Surgical Procedures panel of the Medicare Coverage Advisory Committee will meet on June 12 2002 to discuss whether the federal health plan for the elderly should cover deep brain stimulation for the treatment of Parkinson's disease. The meeting will take place at the Baltimore Convention Center, Room 337-338. Submit formal presentations and written comments to: Michelle Atkinson, executive secretary, CMS Office of Clinical Standards and Quality. Tel: +1 410 786 2881; email: [email protected]

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066322

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel